scholarly article | Q13442814 |
P2093 | author name string | Quintiliani R | |
Nightingale CH | |||
Lawlor MT | |||
Cooper BW | |||
Sullivan MC | |||
P2860 | cites work | The postantibiotic effect: a review of in vitro and in vivo data | Q33617455 |
Ciprofloxacin in acute exacerbations of chronic bronchitis | Q34180747 | ||
Pharmacokinetics of ciprofloxacin after oral and parenteral administration | Q35570646 | ||
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers | Q35640637 | ||
Comparative efficacies of ciprofloxacin, amoxicillin, amoxicillin-clavulanic acid, and cefaclor against experimental Streptococcus pneumoniae respiratory infections in mice | Q36753658 | ||
Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials | Q37901918 | ||
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. | Q39651339 | ||
The mode of action of 4-quinolones and possible mechanisms of resistance | Q39754868 | ||
Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance | Q39828366 | ||
Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model | Q39833928 | ||
Effect of dose size on bioavailability of ciprofloxacin | Q40283886 | ||
Nalidixic Acid: an Antibacterial Paradox | Q40944835 | ||
Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia | Q42106566 | ||
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis | Q42203654 | ||
Factors associated with nephrotoxicity and clinical outcome in patients receiving amikacin | Q42226724 | ||
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model | Q43617611 | ||
Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental animal model | Q43932771 | ||
Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model | Q44090962 | ||
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
Inappropriate use of oral ciprofloxacin | Q45070443 | ||
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. | Q51634358 | ||
Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections. | Q54408341 | ||
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. | Q54765685 | ||
The post-antimicrobial suppressive effect of quinolone agents. | Q54770044 | ||
Evidence for a Slow Elimination Phase for Penicillin G | Q68438201 | ||
The postantibiotic effect | Q69011396 | ||
Kinetics of antimicrobial activity | Q69494182 | ||
Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins | Q69572281 | ||
In vivo postantibiotic effect in a thigh infection in neutropenic mice | Q70370760 | ||
Postantibiotic suppression of bacterial growth | Q71543981 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Streptococcus pneumoniae | Q221179 |
P304 | page(s) | 234-239 | |
P577 | publication date | 1993-02-01 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model | |
P478 | volume | 37 |
Search more.